Erasca Stock Quote ERAS - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

2.63

Bid

2.58

Ask

2.83

Volume

945,515

2.57 Day's Range 2.69

1.64 52 Week Range 3.45

Market Cap

743.573M

Previous Close

2.62

Open

2.69

Last Trade

7490

2.63

(priorref)

Last Trade Time

Financial Volume

$ 2,478,265

VWAP

2.6211

Average Volume (3m)

1,446,241

Shares Outstanding

282,727,282

Dividend Yield

PE Ratio

-5.92

Earnings Per Share (EPS)

-0.44

Revenue

Net Profit

-125.04M

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.erasca.com

Headquarters

Wilmington, Delaware, USA

Founded

Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was $2.62. Over the last year, Erasca shares have traded in a share price range of $ 1.64 to $ 3.45.

Erasca currently has 282,727,282 shares outstanding. The market capitalization of Erasca is $740.75 million. Erasca has a price to earnings ratio (PE ratio) of -5.92.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.35	-11.744966443	2.98	3.05	2.51	1285991	2.72128046	CS
4	-0.09	-3.30882352941	2.72	3.3	2.51	1254344	2.85791732	CS
12	0.04	1.5444015444	2.59	3.305	2.41	1446241	2.79758832	CS
26	0.5	23.4741784038	2.13	3.45	1.96	1912060	2.76990909	CS
52	0.75	39.8936170213	1.88	3.45	1.64	1569070	2.55523124	CS
156	-11.65	-81.5826330532	14.28	16.005	1.51	1041397	3.95025623	CS
260	-13.27	-83.4591194969	15.9	24.47	1.51	960603	4.72046098	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	$ 1.41 (-61.37%)	758.95k
TNYATenaya Therapeutics Inc	$ 1.395 (-51.56%)	42.45M
ORKTOrangeKloud Technology Inc	$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	$ 1.395 (-39.35%)	18.16M
DBGIDigital Brands Group Inc	$ 2.46 (-37.88%)	805.23k
RIMEAlgorhythm Holdings Inc	$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.335 (-36.79%)	1.02B
GOEVCanoo Inc	$ 0.118 (7.08%)	388.43M
NVDANVIDIA Corporation	$ 130.39 (-1.22%)	259.4M
XTIAXTI Aerospace Inc	$ 0.0442 (8.33%)	222.55M